Hostname: page-component-6898cfcb55-kwdml Total loading time: 0 Render date: 2026-11-11T10:23:17.723Z Has data issue: false hasContentIssue false

Efficacy of catheter ablation in ganglionated plexus for malignant vasovagal syncope children

Published online by Cambridge University Press:  04 April 2024

Hongxia Li
Affiliation:
Department of Cardiology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
Wei Shao
Affiliation:
Department of Cardiology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
Xia Yu
Affiliation:
Department of Cardiology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
Lu Gao
Affiliation:
Department of Cardiology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
Yue Yuan*
Affiliation:
Department of Cardiology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
*
Corresponding author: Y. Yuan; Email: yuanyuebj@126.com
Rights & Permissions [Opens in a new window]

Abstract

Aim:

Malignant vasovagal syncope in children seriously affects their physical and mental health. Our study aimed to explore the efficacy of catheter ablation in ganglionated plexus with malignant vasovagal syncope children.

Conclusion:

Catheter ablation of ganglionated plexus was safe and effective in children with malignant vasovagal syncope and can be used as a treatment option for these children.

Methods:

A total of 20 children diagnosed with malignant vasovagal syncope were enrolled in Beijing Children’s Hospital, affiliated with Capital Medical University. All underwent catheter ablation treatment of ganglionated plexus. Ganglionated plexuses of the left atrium were identified by high-frequency stimulation and/or anatomic landmarks being targeted by radiofrequency catheter ablation. The efficacy of the treatment was evaluated by comparing the remission rate of post-operative syncopal symptoms and the rate of negative head-up tilt results. Safety and adverse events were evaluated.

Results:

After follow-up for 2.5 (0.6–5) years, the syncope symptom scores were decreased significantly compared with before treatment [3 (2–4) versus 5 (3–8) scores, P < 0.01]. Eighty-five per cent (17/20) children no longer experienced syncope, whilst 80% (16/20) children showed negative head-up tilt test after treatment. No adverse effects such as cardiac arrhythmia occurred in the children.

Information

Type
Original Article
Copyright
© The Author(s), 2024. Published by Cambridge University Press
Figure 0

Figure 1.DC values were significantly decreased at 1 month, 3 months, 6 months, and 1 year after ablation compared with pre-ablation.

Figure 1

Table 1.Information of vasovagal syncope cardioinhibitory prior to cardio-neuroablation

Figure 2

Table 2.Comparison of parameters in vasovagal syncope children between pre-procedure and post-procedure

Figure 3

Table 3.Comparison of DC values between pre-ablation and post-ablation

Figure 4

Figure 2.The locations of ganglionated plexus were left superior ganglionated plexus, superolateral area around the root of the left superior pulmonary vein, left inferior ganglionated plexus, inferoposterior area around the root of the left inferior pulmonary vein, right anterior ganglionated plexus, supero-anterior area around the root of the right superior pulmonary vein, and right inferior ganglionated plexus, infero-posterior area around the root of the right inferior pulmonary vein.

Figure 5

Figure 3.During  head-up tilt test pre-ablation, a ventricular pause lasting for at least 3 seconds (secondary to atrio-ventricular block followed by a sinus pause of 2 seconds) was observed. In contrast, after ablation, atrio-ventricular block and sinus pauses were no longer noted.